These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9327156)
1. Combinatorial chemistry to develop new drugs. Cancer J Sci Am; 1997; 3(5):312-3. PubMed ID: 9327156 [No Abstract] [Full Text] [Related]
2. Two new criteria for choosing sample size in combinatorial chemistry. Zhao PL; Nachbar RB; Bolognese JA; Chapman K J Med Chem; 1996 Jan; 39(2):350-2. PubMed ID: 8558501 [No Abstract] [Full Text] [Related]
3. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? Newman DJ J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402 [No Abstract] [Full Text] [Related]
4. Comments on the empirical and the rational method for the development of new drugs. An introduction to medicinal chemistry. Lund-Jensen C Pharm Acta Helv; 1967 Apr; 42(4):193-208. PubMed ID: 5582514 [No Abstract] [Full Text] [Related]
5. Microfluidic systems for high-throughput and combinatorial chemistry. Cullen CJ; Wootton RC; de Mello AJ Curr Opin Drug Discov Devel; 2004 Nov; 7(6):798-806. PubMed ID: 15595440 [TBL] [Abstract][Full Text] [Related]
7. Chemical library synthesis using convergent approaches. Beeler AB; Schaus SE; Porco JA Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329 [TBL] [Abstract][Full Text] [Related]
8. Natural product hybrids as new leads for drug discovery. Tietze LF; Bell HP; Chandrasekhar S Angew Chem Int Ed Engl; 2003 Sep; 42(34):3996-4028. PubMed ID: 12973759 [TBL] [Abstract][Full Text] [Related]
9. Automated medicinal chemistry. Koppitz M; Eis K Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909 [TBL] [Abstract][Full Text] [Related]
10. [Studies on the chemistry of drugs. Panegyric or funeral oration?]. Lespagnol A; Lespagnol C Actual Pharmacol (Paris); 1977; 29():155-77. PubMed ID: 868616 [No Abstract] [Full Text] [Related]
11. [Synthetic drugs and natural substances as drugs. Progress in 1963 and 1964]. Hach V Pharmazie; 1966 Jan; 21(1):1-22. PubMed ID: 4861049 [No Abstract] [Full Text] [Related]
12. Diversity-oriented synthesis. Spandl RJ; Díaz-Gavilán M; O'Connell KM; Thomas GL; Spring DR Chem Rec; 2008; 8(3):129-42. PubMed ID: 18563806 [TBL] [Abstract][Full Text] [Related]
13. Continuous flow microreactors for drug discovery. Watts P Curr Opin Drug Discov Devel; 2004 Nov; 7(6):807-12. PubMed ID: 15595441 [TBL] [Abstract][Full Text] [Related]
14. Modern natural products chemistry and drug discovery. Ojima I J Med Chem; 2008 May; 51(9):2587-8. PubMed ID: 18393400 [No Abstract] [Full Text] [Related]
15. The recent impact of solid-phase synthesis on medicinally relevant benzoannelated oxygen heterocycles. Ziegert RE; Toräng J; Knepper K; Bräse S J Comb Chem; 2005; 7(2):147-69. PubMed ID: 15762741 [No Abstract] [Full Text] [Related]
16. Assessment of structural diversity in combinatorial synthesis. Fergus S; Bender A; Spring DR Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333 [TBL] [Abstract][Full Text] [Related]
17. Derivatization reactions of heterocyclic scaffolds on solid phase: tools for the synthesis of drug-like molecule libraries. Felder ER; Brill WK; Martina K Methods Enzymol; 2003; 369():435-69. PubMed ID: 14722967 [No Abstract] [Full Text] [Related]
19. Medicinal chemistry and synthetic drugs. De Haen P N Y State J Med; 1969 Dec; 69(24):3157-62. PubMed ID: 5260810 [No Abstract] [Full Text] [Related]
20. High-throughput and parallel screening methods in asymmetric hydrogenation. Jäkel C; Paciello R Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304 [No Abstract] [Full Text] [Related] [Next] [New Search]